Pivotal phase I trial of captisol-enabled docetaxel (ML 061) in patients with cancer
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Docetaxel (Primary)
- Indications Cancer; Solid tumours
- Focus Registrational; Therapeutic Use
- 26 Nov 2012 New trial record